Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Acute Inflammation III: Local and Systemic Effects

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Awake ECMO for ARDS: No Vent, No VILI, No Problem?

American journal of respiratory and critical care medicine·2026

Same author

The authors reply.

Critical care medicine·2026

Same author

A Qualitative Multicenter Study of Participant Experiences With an App-Based Mindfulness Intervention (Lift 2) for Critical Illness Survivors.

Critical care explorations·2026

Same author

Blueprint 2: A self-directed mobile adaptive coping skills intervention to improve psychological distress symptoms among cardiorespiratory failure survivors study protocol.

Contemporary clinical trials·2026

Same author

Improving Racial Disparities in Lung Cancer Screening Uptake: A Mixed-Methods Study of a Centralized Program.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Patient and Clinician Perspectives on Chronic Pain Communication in Advanced Kidney Disease.

Journal of the American Geriatrics Society·2026

Same journal

Flow Asynchronies During Pressure Support Ventilation in Children: A Bench Model Study.

Respiratory care·2026

Same journal

Inspiratory Effort Assessment Using the Occlusion Pressure-Derived Tension-Time Index.

Respiratory care·2026

Same journal

Clinical Usage of High-Flow Nasal Cannula Across Disease Categories and Care Settings: A Nationwide Cohort Study in Japan.

Respiratory care·2026

Same journal

Efficacy of Mechanical Insufflation-Exsufflation Devices as Analyzed in Lung Models: Systematic Review and Network Meta-Analysis of Peak Expiratory Flow Data.

Respiratory care·2026

Same journal

Overnight Oxygenation and Patient Comfort Using a New Nasal Cannula Versus Standard Cannula in Long-Term Oxygen Therapy.

Respiratory care·2026

Same journal

Effects of Resting Posture on End-Expiratory Lung Impedance and Regional Ventilation Distribution, Assessed Using Electrical Impedance Tomography.

Respiratory care·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 21, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

Persistent systemic inflammation in chronic critical illness.

Christopher E Cox¹

¹Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. christopher.cox@duke.edu

Respiratory Care

|June 6, 2012

Summary

This summary is machine-generated.

Chronic critical illness (CCI) is a complex condition characterized by neuromuscular weakness and organ dysfunction. Early, evidence-based intensive care unit (ICU) management focusing on patient outcomes is crucial for managing patients at risk for CCI.

More Related Videos

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Published on: May 2, 2017

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Related Experiment Videos

Last Updated: May 21, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness

Published on: May 2, 2017

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

Area of Science:

Critical Care Medicine
Intensive Care Unit (ICU) Management
Systemic Inflammation

Background:

Chronic critical illness (CCI) is a complex syndrome involving neuromuscular weakness, brain dysfunction, malnutrition, endocrinopathies, and symptom distress.
Two frameworks conceptualize CCI: a clinical roadmap post-acute illness and the impact of systemic inflammation.
CCI is linked to acute risk factors and systemic inflammation, necessitating early management of inflammatory mediators.

Purpose of the Study:

To discuss conceptual themes in understanding Chronic Critical Illness (CCI).
To link acute CCI risk factors with common clinical features through systemic inflammation.
To emphasize early and continuous management of inflammatory mediators throughout ICU stays.

Main Methods:

Conceptual analysis of Chronic Critical Illness (CCI).
Linking acute CCI risk factors with clinical features via systemic inflammation.
Focusing on patient outcomes rather than solely on biomarkers for intervention effectiveness.

Main Results:

Systemic inflammation plays a key role in the development and features of CCI.
Early and balanced control of pro-inflammatory and anti-inflammatory mediators is recommended.
Biomarkers are often unreliable predictors of intervention effects in CCI.

Conclusions:

Evidence-based, high-quality ICU management is the optimal strategy for patients at risk of CCI.
Managing systemic inflammation early and continuously is vital for patients with or at risk for CCI.
Focusing on patient-reported outcomes is essential due to limitations of surrogate measures like biomarkers.